Structured evidence table for Rosemary Cognitive Performance Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Rosemary Cognitive Performance Meta-Analysis | In the late-onset groups, the apolipoprotein E (APOE) gene, the strongest and most consistently replicated genetic risk factor, is associated with AD. | 3 | Lawal Rasheedat (2026) | Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer’s Disease |
| Rosemary Cognitive Performance Meta-Analysis | The ε4 allele increases the likelihood of developing AD and is associated with greater neuroinflammation and impaired lipid transport []. | 3 | Lawal Rasheedat (2026) | Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer’s Disease |
| Rosemary Cognitive Performance Meta-Analysis | 2 16 17 18 14 19 18 Although individuals with MCI face an elevated risk of progression to Alzheimer’s disease [,,], if not controlled properly [], the trajectories are highly variable. | 3 | Lawal Rasheedat (2026) | Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer’s Disease |
| Rosemary Cognitive Performance Meta-Analysis | 1 2 3 4 Alzheimer’s disease (AD) is the most common cause of dementia [], which accounts for 55.2 million dementia cases estimated globally and is projected to exceed 75.6 million cases by 2030 []. | 3 | Lawal Rasheedat (2026) | Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer’s Disease |
| Rosemary Cognitive Performance Meta-Analysis | This study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Meta-Analysis | Accordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Meta-Analysis | While the evidence surrounding green tea and its relevant constituents is relatively well summarized, the impact that other herbs and phytochemical compounds may have on cognition remains to be systematically reviewed. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Meta-Analysis | tenuiflorum This study addresses the effectiveness of various naturally occurring molecules in improving cognitive functions in healthy adults. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
Source documents